Medical device company Alafair Biosciences has surpassed 12,000 implantations of its flagship product VersaWrap, the only class II medical device intended for use on tendon, ligament, skeletal muscle and peripheral nerve, including on nerve root in spine procedures.
VersaWrap is primarily applied by plastic, orthopedic, hand, foot and ankle, and spine surgeons, according to a Nov. 21 press release.
The product is an ultrathin, sutureless, bioresorbable hydrogel implant that forms a gelatinous layer around target tissues. It facilitates gliding during healing, reducing postoperative tethering.
"In patients where I've applied VersaWrap, they report less pain, greater mobility, and a quicker return to normal routines," Anthony Echo, MD, plastic surgeon at Houston (Texas) Methodist, said in the release.